Penumbra, Inc.
NYSE:PENMedical - Devices
-$2.30 today
- Market cap
- $12.64B
- Beta
- 0.70
- P/E (TTM)
- 72.6
- EPS (TTM)
- $4.36
Volume 0.21M
Average 0.50M
PEN Total Liabilities
Everything the company owes to creditors and other parties.
Penumbra, Inc.NYSE: PEN
Total Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total liabilities rises 16.6% from a year ago
Total liabilities stood at $443.96M at the end of Q2 FY2026, up 16.6% from a year earlier and up 4.6% from the prior quarter. Over 3 fiscal years it compounded at +2.4% a year.
Context
- Total liabilities amounted to 22.5% of total assets at the end of Q2 FY2026, down 0.3 pp from a year earlier.
- Total liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +16.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 398.92M USD
- Year-over-year change
- +4.4%
- 4-year CAGR
- +8.3%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 398.92M | +4.4% |
| FY2024 | 2024-12-31 | 382.25M | +1.3% |
| FY2023 | 2023-12-31 | 377.36M | +1.4% |
| FY2022 | 2022-12-31 | 372.03M | +28.1% |
| FY2021 | 2021-12-31 | 290.32M | — |
Total Liabilities vs competitors
How PEN compares with its peers on the latest reported figures
- PEN's Jun 2026 total liabilities of $443.96M is the 7th highest of the 9 companies compared; the peer median is $3.19B.
- Its year-over-year change of +16.6% is the 3rd highest of 9, against a peer median of +7.0%.
- Total liabilities amounts to 22.5% of total assets for PEN, versus a peer median of 35.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $57.45B | +73.2% | -3.3% | 52.6% | |
| Jul 2026 | $42.46B | -0.9% | +3.0% | 45.5% | |
| Jun 2026 | $20.04B | +6.0% | +8.8% | 44.3% | |
| Sep 2026 | $3.23B | +39.9% | +13.1% | 16.7% | |
| Jun 2026 | $3.14B | +9.0% | +10.6% | 22.7% | |
| Sep 2026 | $1.18B | +7.2% | +28.5% | — | |
| Jun 2026 | $443.96M | +16.6% | +2.4% | 22.5% | |
| Mar 2026 | $222.9M | +6.9% | +73.9% | 35.4% | |
| Feb 2026 | $87.32M | -12.3% | -8.8% | 33.5% | |
| Peer median (excluding PEN) | $3.19B | +7.0% | +9.7% | 35.4% | |
Competitors are the stored peer set for PEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 59.38M | 69.86M | 167.49M | 324.4M | 186.9M |
| Short-term Investments | 195.5M | 118.17M | 121.7M | 15.73M | 357.92M |
| Net Receivables | 133.94M | 203.38M | 201.77M | 167.67M | 190.02M |
| Inventory | 263.5M | 334.01M | 388.02M | 406.74M | 431.55M |
| Other Current Assets | 2.4M | 30.28M | 36.42M | 36.59M | 50.3M |
| Total Current Assets | 681.47M | 755.7M | 915.4M | 951.13M | 1.22B |
| Property, Plant & Equipment (Net) | 227.09M | 280.41M | 280.5M | 267.76M | 316.35M |
| Goodwill | 166.39M | 166.05M | 166.27M | 165.83M | 166.75M |
| Intangible Assets | 90.62M | 91.72M | 83.1M | 7.2M | 6.83M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 65.7M | 64.21M | 85.16M | 100.33M | 79.19M |
| Other Non-current Assets | 12.99M | 12.79M | 25.88M | 40.94M | 40.72M |
| Total Non-current Assets | 562.78M | 615.19M | 640.9M | 582.06M | 609.84M |
| Total Assets | 1.24B | 1.37B | 1.56B | 1.53B | 1.83B |
| Account Payables | 13.42M | 26.68M | 27.16M | 31.33M | 34.74M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 9.16M | 6.99M | 940K | 0 |
| Other Current Liabilities | 0 | 0 | 0 | (940K) | 0 |
| Total Current Liabilities | 123.2M | 144.93M | 151.14M | 158.35M | 183.13M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 3.56M | 3.28M | 5.31M | 15.11M | 12.32M |
| Total Non-current Liabilities | 167.13M | 227.1M | 226.22M | 223.91M | 215.78M |
| Total Liabilities | 290.32M | 372.03M | 377.36M | 382.25M | 398.92M |
| Common Stock | 37K | 38K | 39K | 38K | 39K |
| Retained Earnings | 45.91M | 43.9M | 134.86M | 60M | 237.69M |
| Accumulated OCI | (2.63M) | (8.12M) | (3.15M) | (5.84M) | 4.35M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 953.93M | 998.86M | 1.18B | 1.15B | 1.43B |
| Total Debt | 173.55M | 235.77M | 234.34M | 223.39M | 219.7M |
| Net Debt | 114.17M | 165.92M | 66.86M | (101.02M) | 32.8M |
Penumbra, Inc.
NYSE:PEN
Intrinsic Alpha fair value
Locked
Current Price
$320.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.